Insider Trader Watch: Avadel Pharmaceuticals PLC. $AVDL

analysis-680572_1920

Avadel Pharmaceuticals PLC. (AVDL) insider have most recently took part in a trading activity. On Dec 15, 2017 Stapleton Craig R, Director bought 140,000 shares having total worth of $1,213,800 at the price of $8.67 per share, following the transaction a total of 503,413 shares owned by Stapleton Craig R. Before this latest buy, Stapleton Craig R purchased AVDL at 2 other times during the past twelve months, for a total investment of $495,878 at an average of $9.69 per share.

The stock has experienced a total of 2 insider trades in the past three months. These trades include 1 sell activities and 1 buy trades. Furthermore, over the past 12 months , the stock was traded 11 times by insiders. In 3 of these trades, the insider was a seller while an employee of the company was the buyer in 8 instances.

Time Frame Number of Insider Buy Number of Insider Sell Stock Price Change(%)
3 Month 1 1 0.59%
12 Month 8 3 -26.83%

Shares of Avadel Pharmaceuticals PLC. (AVDL) traded down 1.96% on Dec 18, 2017, hitting $8.51. 124,701 shares of the company’s stock traded hands. Avadel Pharmaceuticals PLC. has a 52 week low of $8.09 and a 52 week high of $14.89. The company’s market cap is $0 million.

William White

William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.

About the Author

William White
William White is a financial writer. He graduated with a degree in Economics. He has contributed to major financial websites and print publications for over 8 years. He handles much of this site's news coverage for corporate insider activity, and occasionally cover other areas of financial sector.